Role of Chitrakadi Vati in gastrointestinal disorders - A Review Article

Abstract

Introduction:Chitrakadi Vati, an Ayurvedic formulation primarily containing Chitrak (Plumbago zeylanica), is traditionally used for gastrointestinal disorders. It is known for its carminative, digestive, and anti-inflammatory actions, with relevance in conditions like dyspepsia and irritable bowel syndrome (IBS). Methods:Literature from Ayurvedic texts, and modern scientific databases was reviewed to assess the pharmacological mechanisms and clinical applications of Chitrakadi Vati. Results:Findings suggest that Chitrakadi Vati enhances gastric motility, promotes bile secretion, and regulates digestion. Clinical studies indicate benefits in reducing abdominal discomfort, bloating, and irregular bowel movements. Antioxidant activity further supports gut health by reducing oxidative stress. Discussion:Chitrakadi Vati shows promise as a complementary therapy for gastrointestinal ailments. While traditional use aligns with preliminary evidence, large scale clinical trials are needed to validate efficacy and establish safety in modern ppractice.Conclusion:Chitrakadi Vati emerges as a significant Ayurvedic formulation in the management of gastrointestinal issues, offering a holistic approach to enhancing digestive health. Its carefully selected blend of herbal ingredients provides various therapeutic benefits, including carminative, anti- inflammatory, and digestive-stimulating effects.

References

1. https://www.gastrojournal.org/article/S0016-5085(23)00825 9/fulltext#:~:text=Little%20to%20no%20decrease%20in,was%20102%20per%2 0100% 2C000%20individuals.
2. Tripathi B. Astanga Hridayam. Nirmala Hindi Commentary. Varanasi: Chaukhamba Sanskrit Pratishthan; 2003. Chapter 12, verses 171–172.
3. Shastri H, editor. Rasatarangini (Prasadani Commentary). 11th ed. New Delhi: Motilal Banarasidas; 2000. P. 128. Kumar PB, et al. Role of Chitrakadi Vati in Grahani Dosha. Int Ayurvedic Med J (IAMJ). 2016;4(2):128. Available from: www.iamj.in
4. Chetty KM, et al. Pharmaceutical studies and therapeutic uses of Plumbago zeylanica L. roots (Chitraka, Chitramulamu). Ethnobotanical Leaflets. 2006;10:294–304.
5. Bhavamishra, Bhavprakasha, Vol 1, Chaukhamba Bharti Academy, Varanasi, 1993.
6. P.V. Sharma, Dravyaguna vijnana, Volume 2, Chaukhamba Bharati Academy varanasi, 256, 335, 340, 350, 497.
7. Charaka Samhita. Chakrapanidatta Commentary. Edited by Acharya YT. Varanasi: Chaukhamba Surbharati Prakashana; 2009. Chikitsa Sthana 15/71.
8. Central Council for Research in Ayurvedic Sciences (CCRAS). The Ayurvedic Formulary of India. 2nd ed. Part I. Vol I. New Delhi: Govt. of India, Ministry of Health and Family Welfare; 2003. P. 465.
9. Charaka Samhita. Chakrapanidatta Commentary. Edited by Acharya YT. Varanasi: Chaukhamba Surbharati Prakashana; 2009. Chikitsa Sthana 15/42–44.
10. Bhavamishra. Bhavaprakasha. 9th ed. Vol I. Varanasi: Chaukhamba Bharati Academy; 1993.
11. Sharma PV. Dravya Guna Vijnana. Vol I, III. Varanasi: Chaukhamba Orientalia; 2006.
12. Vaidya Bapalal G. Nigantu Adarsha. 2nd ed. Vol I–II. Varanasi: Chaukhamba Bharati Academy; 2013.
13. Charaka Samhita. Chakrapanidatta Commentary. Edited by Acharya YT. Varanasi: Chaukhamba Surbharati Prakashana; 2009.
14. Ram A. Effect of Plumbago zeylanica in hyperlipidaemic rabbits and its modification by vitamin E. Indian J Pharmacol. 1996;28:161–6.
15. Vedhanayaki G, Shastri GV, Kuruvilla A. Analgesic activity of Piper longum Linn. Root. Indian J Exp Biol. 2003;41(6):649–51.
16. Agrawal AK, Rao CV, Sairam K, Joshi VK, Goel RK. Effect of Piper longum, Zingiber officinale Linn. And Ferula species on gastric ulceration and secretion in rats. Indian J Exp Biol. 2000;38:994–8.
17. Khajuria A, Zutshi U, Bedi KL. Intestinal permeability characteristics of piperine, an active alkaloid from peppers and bioavailability enhancer. Indian J Exp Biol. 1998;36(1):46–50.
18. Dr. Singh Jagdev, Chitrakadi Vati, http://www.ayurtime.com>chitrakadivati, 2015. Ayur time, Sep 12,